Gary Ingenito
Chief Tech/Sci/R&D Officer at CATALYST PHARMACEUTICALS, INC.
Net worth: 819 173 $ as of 31/03/2024
Profile
Gary Ingenito is currently the Chief Medical & Regulatory Officer at Catalyst Pharmaceuticals, Inc. He previously held positions as Senior Vice President at inVentiv Health Clinical, Inc. from 2003 to 2005, Senior Vice President-Scientific Affairs at Ontrak, Inc., Chief Clinical & Regulatory Affairs Officer at Angiotech Pharmaceuticals, Inc. from 2005 to 2008, Head-Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc., and Head-Medical Affairs at Sandoz Pharmaceuticals Corp.
Dr. Ingenito has a doctorate degree from Thomas Jefferson University and Sidney Kimmel Medical College, an undergraduate degree from The Johns Hopkins University, and a graduate degree from the University of Miami.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/02/2024 | 51,391 ( 0.04% ) | 819 173 $ | 31/03/2024 |
Gary Ingenito active positions
| Companies | Position | Start |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
Former positions of Gary Ingenito
| Companies | Position | End |
|---|---|---|
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 29/02/2008 |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/01/2005 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | General Counsel | - |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| ONTRAK, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Gary Ingenito
| Thomas Jefferson University | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
| University of Miami | Graduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ONTRAK, INC. | Health Services |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
| Sandoz Pharmaceuticals Corp. |
- Stock Market
- Insiders
- Gary Ingenito
